Table of Contents Author Guidelines Submit a Manuscript
The Scientific World Journal
Volume 2014, Article ID 260348, 18 pages
http://dx.doi.org/10.1155/2014/260348
Review Article

Proteomic Approaches in Biomarker Discovery: New Perspectives in Cancer Diagnostics

Medical Centre for Molecular Biology, Institute of Biochemistry, Faculty of Medicine, University of Ljubljana, Vrazov trg 2, 1000 Ljubljana, Slovenia

Received 30 August 2013; Accepted 8 October 2013; Published 14 January 2014

Academic Editors: P. Cassoni and L. Messerini

Copyright © 2014 Petra Hudler et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [21 citations]

The following is the list of published articles that have cited the current article.

  • Tove Boström, Henrik J. Johansson, Janne Lehtiö, Mathias Uhlén, and Sophia Hober, “Investigating the Applicability of Antibodies Generated within the Human Protein Atlas as Capture Agents in Immunoenrichment Coupled to Mass Spectrometry,” Journal of Proteome Research, pp. 140925073505009, 2014. View at Publisher · View at Google Scholar
  • Fang Yao, Chi Zhang, Wei Du, Chao Liu, and Ying Xu, “Identification of Gene-Expression Signatures and Protein Markers for Breast Cancer Grading and Staging,” Plos One, vol. 10, no. 9, 2015. View at Publisher · View at Google Scholar
  • Xiumin Shi, Jianting Xu, Jihan Wang, Meizi Cui, Yushun Gao, Haitao Niu, and Haofan Jin, “Expression analysis of apolipoprotein E and its associated genes in gastric cancer,” Oncology Letters, vol. 10, no. 3, pp. 1309–1314, 2015. View at Publisher · View at Google Scholar
  • Richard Batrla, and Bruce W.M. Jordan, “Personalized health care beyond oncology: new indications for immunoassay-based companion diagnostics,” Annals of the New York Academy of Sciences, 2015. View at Publisher · View at Google Scholar
  • Miao Jiang, Qinglin Zha, Chi Zhang, Cheng Lu, Xiaoping Yan, Wanhua Zhu, Wei Liu, Shenghao Tu, Liping Hou, Chengwu Wang, Wandong Zhang, Qinghua Liang, Bing Fan, Jiangping Yu, Weidong Zhang, Xinru Liu, Jing Yang, Xiaojuan He, Li Li, Xuyan Niu, Yan Liu, Hongtao Guo, Bing He, Ge Zhang, Zhaoxiang Bian, and Aiping Lu, “Predicting and verifying outcome of Tripterygium wilfordii Hook F. based therapy in rheumatoid arthritis: from open to double-blinded randomized trial,” Scientific Reports, vol. 5, 2015. View at Publisher · View at Google Scholar
  • Pei-Wei Zhang, Lei Chen, Tao Huang, Ning Zhang, Xiang-Yin Kong, and Yu-Dong Cai, “Classifying Ten Types of Major Cancers Based on Reverse Phase Protein Array Profiles,” Plos One, vol. 10, no. 3, 2015. View at Publisher · View at Google Scholar
  • Namita Pendharkar, Akshada Gajbhiye, Khushman Taunk, Sourav Roy Choudhury, Snigdha Dhali, Shubhendu Seal, Anupama Mane, Subodhini Abhang, Manas K. Santra, Koel Chaudhury, and Srikanth Rapole, “Quantitative tissue proteomic investigation of invasive ductal carcinoma of breast with luminal B HER2 positive and HER2 enriched subtypes towards potential diagnostic and therapeutic biomarkers,” Journal of Proteomics, 2015. View at Publisher · View at Google Scholar
  • Petra Hudler, “Challenges of deciphering gastric cancer heterogeneity,” World Journal of Gastroenterology, vol. 21, no. 37, pp. 10510–10527, 2015. View at Publisher · View at Google Scholar
  • Pranov Ramana, Erwin Adams, Patrick Augustijns, and Ann Van Schepdael, “Metabonomics and drug development,” Methods in Molecular Biology, vol. 1277, pp. 195–207, 2015. View at Publisher · View at Google Scholar
  • Alja Videtic Paska, and Petra Hudler, “Aberrant methylation patterns in cancer: A clinical view,” Biochemia Medica, vol. 25, no. 2, pp. 161–176, 2015. View at Publisher · View at Google Scholar
  • Akshada Gajbhiye, Raju Dabhi, Khushman Taunk, Garikapati Vannuruswamy, Sourav RoyChoudhury, Ragini Adhav, Shubhendu Seal, Anupama Mane, Santhakumari Bayatigeri, Manas K. Santra, Koel Chaudhury, and Srikanth Rapole, “Urinary proteome alterations in HER2 enriched breast cancer revealed by multipronged quantitative proteomics,” Proteomics, 2016. View at Publisher · View at Google Scholar
  • Mikel Azkargorta, Javier Soria, Arantxa Acera, Ibon Iloro, Tatiana Suarez, and Felix Elortza, “Human tear proteomics and peptidomics in ophthalmology: Toward the translation of proteomic biomarkers into clinical practice,” Journal of Proteomics, 2016. View at Publisher · View at Google Scholar
  • Jihye Shin, Gamin Kim, Jong Won Lee, Ji Eun Lee, Yoo Seok Kim, Jong-Han Yu, Seung-Taek Lee, Sei Hyun Ahn, Hoguen Kim, and Cheolju Lee, “Identification of ganglioside GM2 activator playing a role in cancer cell migration through proteomic analysis of breast cancer secretomes,” Cancer Science, vol. 107, no. 6, pp. 828–835, 2016. View at Publisher · View at Google Scholar
  • Lee Admoni-Elisha, Itay Nakdimon, Anna Shteinfer, Tal Prezma, Tasleem Arif, Nir Arbel, Anna Melkov, Ori Zelichov, Itai Levi, and Varda Shoshan-Barmatz, “Novel Biomarker Proteins in Chronic Lymphocytic Leukemia: Impact on Diagnosis, Prognosis and Treatment,” Plos One, vol. 11, no. 4, 2016. View at Publisher · View at Google Scholar
  • Hyunsoo Kim, JiYoung Park, Yongkang Kim, Areum Sohn, Injun Yeo, Su Jong Yu, Jung-Hwan Yoon, Taesung Park, and Youngsoo Kim, “Serum fibronectin distinguishes the early stages of hepatocellular carcinoma,” Scientific Reports, vol. 7, no. 1, 2017. View at Publisher · View at Google Scholar
  • Vito Michele Garrisi, Nicola Sgherza, Massimo Breccia, Angela Iacobazzi, Giacoma De Tullio, Giovanni Nardelli, Antonio Negri, Rosa Divella, Antonella Daniele, Giuseppina Micelli, Antonio Tufaro, Nicola Cascavilla, Eufemia Savino, Ines Abbate, and Attilio Guarini, “Association between proteomic profile and molecular response in chronic myeloid leukemia patients,” Leukemia & Lymphoma, pp. 1–3, 2017. View at Publisher · View at Google Scholar
  • Henry A. Adeola, Jonathan M. Blackburn, Timothy R. Rebbeck, and Luiz F. Zerbini, “Emerging proteomics biomarkers and prostate cancer burden in Africa,” Oncotarget, vol. 8, no. 23, pp. 37991–38007, 2017. View at Publisher · View at Google Scholar
  • Kalpana Joshi, and Dada Patil, “Proteomics,” Innovative Approaches in Drug Discovery, pp. 273–294, 2017. View at Publisher · View at Google Scholar
  • Rongrong Huang, Zhongsi Chen, Lei He, Nongyue He, Zhijiang Xi, Zhiyang Li, Yan Deng, and Xin Zeng, “Mass spectrometry-assisted gel-based proteomics in cancer biomarker discovery: approaches and application.,” Theranostics, vol. 7, no. 14, pp. 3559–3572, 2017. View at Publisher · View at Google Scholar
  • Anna Kwiecińska, Anna Porwit, Nazariy Souchelnytskyi, Ann Kaufeldt, Catharina Larsson, Svetlana Bajalica-Lagercrantz, and Serhiy  Souchelnytskyi, “Proteomic Profiling of Diffuse Large B-Cell Lymphomas,” Pathobiology, vol. 85, no. 4, pp. 211–219, 2018. View at Publisher · View at Google Scholar
  • Khushman Taunk, Ravindra Taware, Tushar H. More, Priscilla Porto-Figueira, Jorge A. M. Pereira, Rajkishore Mohapatra, Dharmesh Soneji, José S. Câmara, H. A. Nagarajaram, and Srikanth Rapole, “A non-invasive approach to explore the discriminatory potential of the urinary volatilome of invasive ductal carcinoma of the breast,” RSC Advances, vol. 8, no. 44, pp. 25040–25050, 2018. View at Publisher · View at Google Scholar